Trial Profile
The Effect of Tecfidera (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms TECONGUT
- Sponsors Biogen
- 01 Feb 2018 Status changed from recruiting to completed.
- 22 Nov 2016 Planned End Date changed from 1 Feb 2017 to 1 Jun 2017.
- 22 Nov 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017.